BRISTOL SEES OPPORTUNITY IN DEVICES

Bristol-Myers Squibb Chief Executive Peter Dolan recently said that he was looking to further expand the company into areas outside the volatile pharmaceuticals business, including medical devices. He also said Bristol would consider acquiring a small biotechnology company to broaden its portfolio of biologic-based drugs.

Reuters (http://today.reuters.com/business/NewsArticle.aspx?type=businessIndustry&storyID=2005-11-08T185142Z_01_ARM855456_RTRIDST_0_BUSINESSPROIND-SUMMIT-BRISTOL-DEVICES-DC.XML)